BCR and diffuse large B-cell lymphoma: In activated B-cell type diffuse large B-cell lymphoma (ABC-DLBCL), activating mutations in B-cell receptor subunits are present in approximately 23% of cases and result in constitutive BCR-driven CBM-dependent NF-κB activity (37–39).